Person › Details

Paul Fry (Vectura Group plc (LSE: VEC))

Fry, Paul (Vectura 202010 CFO before Immunocore + Vodafone + GSK)

	Organisation	Vectura Group plc (LSE: VEC)
	Group	Vectura (Group)
	Former/major organisation	Immunocore Ltd.
	Group	Immunocore (Group)
	Product	ImmTAC therapeutic (Immune mobilising mTCR Against Cancer molecule)
	Product 2	ImmTAC technology

Record changed: 2020-10-09

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]